New Delta-5-Desaturase Inhibitor Suppress Lung Cancer Progression: A Paradigm Shift on COX-2 Biology in Lung Cancer Treatment

被引：0
|
作者：
Pang, Lizhi [1 ]
Shah, Harshit [1 ]
Zhao, Pinjing [1 ]
Qian, Steven [1 ]
Sathish, Venkatachalem [1 ]
机构：
[1] North Dakota State Univ, Fargo, ND USA
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.09700
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immuno-oncology-the new paradigm of lung cancer treatment
    Dawe, D. E.
    Harlos, C. H.
    Juergens, R. A.
    CURRENT ONCOLOGY, 2020, 27 : S78 - S86
  • [42] A Paradigm Shift in the Treatment of Advanced Non-Small Cell Lung Cancer
    Varughese, Shibu
    Jahangir, K. Saad
    Simpson, Catherine E.
    Boulmay, Brian C.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (02): : 147 - 150
  • [43] Immunotherapy is Here to Stay: A New Treatment Paradigm in Lung Cancer
    Rocha, Pedro
    Arriola, Edurne
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (03): : 124 - 125
  • [44] PACER IncRNA Regulates COX-2 Expression in Lung Cancer Cell Lines
    Desind, Samuel Z.
    Iacona, Joseph R.
    Yu, Christina Y.
    Mitrofanova, Antonina
    Lutz, Carol S.
    FASEB JOURNAL, 2022, 36
  • [45] Regulation of COX-2 expression by miR-146a in lung cancer cells
    Cornett, Ashley L.
    Lutz, Carol S.
    RNA, 2014, 20 (09) : 1419 - 1430
  • [46] Could COX-2 Inhibitors Enhance the Outcomes of Chemotherapeutic Agents in Lung Cancer?
    Hohenforst-Schmidt, Woffgang
    Domvri, Kalliopi
    Zarogoulidis, Paul
    Zogas, Nikolaos
    Petanidis, Savvas
    Kioseoglou, Efi
    Zachariadis, George
    Porpodis, Konstantinos
    Zarogoulidis, Konstantinos
    Kontakiotis, Theodor
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1282 - S1283
  • [47] Methanandamide increases COX-2 expression and tumor growth in murine lung cancer
    Gardner, B
    Zhu, LX
    Sharma, S
    Tashkin, DP
    Dubinett, SM
    FASEB JOURNAL, 2003, 17 (12): : 2157 - +
  • [48] Targeting COX-2/PG-E2 with a COX-2 inhibitor in combination with chemotherapy for non-small cell lung cancer: Are we ready for phase III?
    Aisner, J
    CANCER JOURNAL, 2005, 11 (03): : 201 - 203
  • [49] Cox-2 in non-small cell lung cancer: A meta-analysis
    Jiang, Hao
    Wang, Jing
    Zhao, Wei
    CLINICA CHIMICA ACTA, 2013, 419 : 26 - 32
  • [50] LUNG CANCER TREATMENT: A PARADIGM SHIFT TO TARGETED THERAPIES IN CLINICAL TRIAL SETTINGS IN ASIA
    Gupta, J.
    Gupta, P.
    Kaur, H.
    Jindal, R.
    VALUE IN HEALTH, 2012, 15 (07) : A623 - A623
12345